CAD 0.04
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -392.21 Thousand CAD | 46.13% |
2022 | -712.19 Thousand CAD | 42.42% |
2021 | -2.19 Million CAD | -779.26% |
2020 | -9.87 Million CAD | 113.24% |
2019 | -1.87 Million CAD | 84.29% |
2018 | -8.85 Million CAD | -646.06% |
2017 | -1.73 Million CAD | 28.8% |
2016 | -1.47 Million CAD | -224.62% |
2015 | -533.19 Thousand CAD | -19.91% |
2014 | -454.32 Thousand CAD | -23.64% |
2013 | -440.65 Thousand CAD | -0.43% |
2012 | -1.19 Million CAD | 0.0% |
2011 | - CAD | 100.0% |
2010 | -1.61 Million CAD | 54.96% |
2009 | -1.35 Million CAD | 38.16% |
2008 | -2.33 Million CAD | 33.65% |
2007 | -1.89 Million CAD | -293.24% |
2006 | -482.61 Thousand CAD | 54.57% |
2005 | -1.06 Million CAD | -4565.05% |
2004 | -22.77 Thousand CAD | 8.06% |
2003 | -24.76 Thousand CAD | 64.31% |
2002 | -69.4 Thousand CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -38.53 Thousand CAD | 48.17% |
2024 Q2 | -12.8 Thousand CAD | 78.16% |
2023 Q2 | -119.96 Thousand CAD | -2.92% |
2023 FY | - CAD | 45.48% |
2023 Q4 | -73.62 Thousand CAD | 15.13% |
2023 Q3 | -86.74 Thousand CAD | 27.69% |
2023 Q1 | -116.56 Thousand CAD | 53.53% |
2022 FY | - CAD | 42.42% |
2022 Q4 | -250.84 Thousand CAD | -317.27% |
2022 Q1 | -135.16 Thousand CAD | 56.04% |
2022 Q2 | -281.91 Thousand CAD | -108.58% |
2022 Q3 | -60.11 Thousand CAD | 78.68% |
2021 Q4 | -307.48 Thousand CAD | -106.72% |
2021 FY | - CAD | -779.26% |
2021 Q1 | -591.8 Thousand CAD | -342.23% |
2021 Q2 | -216.44 Thousand CAD | 63.43% |
2021 Q3 | -148.74 Thousand CAD | 31.28% |
2020 FY | - CAD | 113.24% |
2020 Q1 | -418.18 Thousand CAD | 19.6% |
2020 Q4 | 244.31 Thousand CAD | -59.23% |
2020 Q3 | 599.21 Thousand CAD | 350.52% |
2020 Q2 | -239.19 Thousand CAD | 42.8% |
2019 Q1 | -327.05 Thousand CAD | 59.56% |
2019 Q3 | -208.6 Thousand CAD | 38.86% |
2019 Q4 | -520.15 Thousand CAD | -149.35% |
2019 FY | - CAD | 84.29% |
2019 Q2 | -341.2 Thousand CAD | -4.33% |
2018 Q1 | -6.22 Million CAD | -8657.6% |
2018 Q2 | -1.17 Million CAD | 81.07% |
2018 Q4 | -808.68 Thousand CAD | -9.07% |
2018 Q3 | -741.4 Thousand CAD | 37.06% |
2018 FY | - CAD | -646.06% |
2017 FY | - CAD | 28.8% |
2017 Q2 | -366.84 Thousand CAD | -116.57% |
2017 Q1 | -169.39 Thousand CAD | 64.86% |
2017 Q4 | -71.04 Thousand CAD | 87.83% |
2017 Q3 | -583.82 Thousand CAD | -59.15% |
2016 Q3 | -213.32 Thousand CAD | 75.49% |
2016 Q1 | -120.09 Thousand CAD | 40.51% |
2016 Q4 | -482.02 Thousand CAD | -125.95% |
2016 FY | - CAD | -224.62% |
2016 Q2 | -870.34 Thousand CAD | -624.69% |
2015 Q2 | -136.22 Thousand CAD | -40.94% |
2015 Q4 | -201.86 Thousand CAD | -139.56% |
2015 FY | - CAD | -19.91% |
2015 Q1 | -96.65 Thousand CAD | 33.81% |
2015 Q3 | -84.26 Thousand CAD | 38.14% |
2014 Q1 | -63.35 Thousand CAD | 34.83% |
2014 FY | - CAD | -23.64% |
2014 Q4 | -146.02 Thousand CAD | -25.1% |
2014 Q3 | -116.72 Thousand CAD | -9.37% |
2014 Q2 | -106.73 Thousand CAD | -68.47% |
2013 Q1 | -33.47 Thousand CAD | 96.61% |
2013 Q2 | -72.55 Thousand CAD | -116.78% |
2013 Q3 | -68.32 Thousand CAD | 5.84% |
2013 FY | - CAD | -0.43% |
2013 Q4 | -97.2 Thousand CAD | -42.27% |
2012 Q3 | -91.11 Thousand CAD | -12.6% |
2012 Q1 | -48.95 Thousand CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q4 | -986.72 Thousand CAD | -982.96% |
2012 Q2 | -80.91 Thousand CAD | -65.3% |
2011 Q2 | -277.96 Thousand CAD | 6.67% |
2011 Q1 | -297.82 Thousand CAD | -157.57% |
2011 Q3 | -181.1 Thousand CAD | 34.85% |
2011 FY | - CAD | 100.0% |
2010 Q3 | -142.4 Thousand CAD | 56.6% |
2010 Q4 | 517.32 Thousand CAD | 463.27% |
2010 FY | - CAD | 54.96% |
2010 Q1 | -397.49 Thousand CAD | -100.31% |
2010 Q2 | -328.12 Thousand CAD | 17.45% |
2009 Q4 | -198.44 Thousand CAD | 11.37% |
2009 FY | - CAD | 38.16% |
2009 Q1 | -91.1 Thousand CAD | 90.07% |
2009 Q2 | -217.91 Thousand CAD | -139.2% |
2009 Q3 | -223.89 Thousand CAD | -2.74% |
2008 Q2 | -310.3 Thousand CAD | -128.72% |
2008 FY | - CAD | 33.65% |
2008 Q1 | -135.67 Thousand CAD | 83.17% |
2008 Q4 | -917.61 Thousand CAD | -415.59% |
2008 Q3 | -177.97 Thousand CAD | 42.65% |
2007 Q3 | -234.76 Thousand CAD | -13.12% |
2007 Q2 | -207.52 Thousand CAD | 68.05% |
2007 Q1 | -649.46 Thousand CAD | -246.29% |
2007 FY | - CAD | -293.24% |
2007 Q4 | -806.11 Thousand CAD | -243.38% |
2006 Q2 | -112.64 Thousand CAD | -48.16% |
2006 FY | - CAD | 54.57% |
2006 Q4 | -187.54 Thousand CAD | -76.17% |
2006 Q1 | -76.03 Thousand CAD | 39.47% |
2006 Q3 | -106.45 Thousand CAD | 5.49% |
2005 Q4 | -125.6 Thousand CAD | -37.91% |
2005 Q2 | -83.75 Thousand CAD | 89.01% |
2005 Q1 | -761.83 Thousand CAD | -1300.8% |
2005 FY | - CAD | -4565.05% |
2005 Q3 | -91.07 Thousand CAD | -8.74% |
2004 FY | - CAD | 8.06% |
2004 Q1 | -44.99 Thousand CAD | -411.82% |
2004 Q3 | -27.1 Thousand CAD | -92.15% |
2004 Q4 | 63.44 Thousand CAD | 334.04% |
2004 Q2 | -14.1 Thousand CAD | 68.65% |
2003 FY | - CAD | 64.31% |
2003 Q3 | -3692.00 CAD | 55.29% |
2003 Q1 | -4025.00 CAD | 0.0% |
2003 Q2 | -8257.00 CAD | -105.14% |
2003 Q4 | -8792.00 CAD | -138.14% |
2002 FY | - CAD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aion Therapeutic Inc. | -6.07 Million CAD | 93.542% |
Ayurcann Holdings Corp. | -2.01 Million CAD | 80.492% |
Blueberries Medical Corp. | -1.22 Million CAD | 67.898% |
The BC Bud Corporation | -1.19 Million CAD | 67.206% |
BioNxt Solutions Inc. | -6.48 Million CAD | 93.952% |
CordovaCann Corp. | -1.6 Million CAD | 75.527% |
Christina Lake Cannabis Corp. | -2.62 Million CAD | 85.05% |
Captor Capital Corp. | 2.42 Million CAD | 116.199% |
City View Green Holdings Inc. | -2.01 Million CAD | 80.53% |
1CM Inc. | 1.31 Million CAD | 129.86% |
Global Hemp Group Inc. | -24.79 Thousand CAD | -1481.963% |
Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 82.24% |
IM Cannabis Corp. | -2.79 Million CAD | 85.942% |
Lobe Sciences Ltd. | -4.4 Million CAD | 91.091% |
Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 87.716% |
Nextleaf Solutions Ltd. | 1.14 Million CAD | 134.357% |
Ovation Science Inc. | -778.83 Thousand CAD | 49.64% |
Pharmadrug Inc. | -1.33 Million CAD | 70.621% |
Captiva Verde Wellness Corp. | -6.05 Million CAD | 93.524% |
RAMM Pharma Corp. | -6.3 Million CAD | 93.776% |
RIV Capital Inc. | -20.28 Million CAD | 98.066% |
Revive Therapeutics Ltd. | -5.59 Million CAD | 92.99% |
Red White & Bloom Brands Inc. | -77.59 Million CAD | 99.495% |
SLANG Worldwide Inc. | -2.95 Million CAD | 86.708% |
1933 Industries Inc. | -10.03 Million CAD | 96.091% |
Red Light Holland Corp. | -5.25 Million CAD | 92.538% |
Top Strike Resources Corp. | -767.99 Thousand CAD | 48.93% |
Xebra Brands Ltd. | -1.49 Million CAD | 73.765% |
Adastra Holdings Ltd. | -1.41 Million CAD | 72.208% |